Ignite Creation Date:
2025-12-25 @ 1:12 AM
Ignite Modification Date:
2026-06-06 @ 7:13 PM
Study NCT ID:
NCT00005793
Status:
COMPLETED
Last Update Posted:
2012-09-25
First Post:
2000-06-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Leukemia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | untreated adult acute myeloid leukemia | View |
| None | adult acute erythroid leukemia (M6) | View |
| None | adult acute myeloblastic leukemia without maturation (M1) | View |
| None | adult acute myeloblastic leukemia with maturation (M2) | View |
| None | adult acute myelomonocytic leukemia (M4) | View |
| None | adult acute monoblastic leukemia (M5a) | View |
| None | adult acute megakaryoblastic leukemia (M7) | View |
| None | adult acute monocytic leukemia (M5b) | View |
| None | adult acute minimally differentiated myeloid leukemia (M0) | View |
| None | adult acute myeloid leukemia with 11q23 (MLL) abnormalities | View |
| None | adult acute myeloid leukemia with inv(16)(p13;q22) | View |
| None | adult acute myeloid leukemia with t(16;16)(p13;q22) | View |
| None | adult acute myeloid leukemia with t(8;21)(q22;q22) | View |